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Abstract

Methyl farnesoate (MF) is a crustacean compound that is structurally
similar to juvenile hormone, a substance that regulates insect growth and
reproduction. This similarity has led to the suggestion that MF may have
juvenile hormone-like effects in crustaceans.

If this is so, regulation of MF

levels might be an important mechanism in the control of crustacean molting and
reproduction. The understanding of, and ability to manipulate, the regulation of

MF production could be a powerful tool in the aquaculture of economically
Important crustaceans.
In the lobster Homarus americanus, MF synthesis occurs in the mandibular organ (MO).

In vivo studies have shown that MF synthesis is negatively

regulated by the sinus gland (SG), a structure located in the crustacean eyestalk
end known to produce neuropeptides. To determine the effect of SG peptides
on MF synthesis, fragments of MO tissue were incubated in culture medium
supplemented with radiolabeled methionine (a precursor of MF). I used this in

vitro bioassay'to compare the activity of a crude SG extract with that of two
peptides purified from the extract. The crude SG extract produced a substantial
decrease in MF synthesis by MO fragments when compared with controls.

One

of the purified peptides also inhibited MF synthesis, but the other had no effect.
The data suggest that the first peptide is the MOIH (mandibular organ inhibiting
hormone) for the lobster.

However, its inhibitory effect on MF production is not

as complete as that of the crude SG extract, suggesting that this peptide may act
synergistically with another compound from the SG to produce full inhibition.
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Introduction
Regulation of reproduction and metamorphosis in insects
The reproduction and metamorphosis of all arthropods is controlled by a
",umber of endocrine compounds. These hormones circulate in the hemolymph
(blood in an open circulatory system) and serve as chemical messengers
between organs.

In insects, two groups of hormones have central roles in both

reproduction and metamorphosis: the ecdysteroids and the juvenile hormone

(JH) analogues. Ecdysteroids are steroid hormones produced by the
prothoracic glands, paired organs found in close association with the brain. JH
a sesquiterpenoid hormone produced by the corpora allata, another pair of
e''ldocrine glands close to the brain.
Insects grow by a process called molting. During molting, the older
exoskeleton is shed and replaced by a newer exoskeleton. This periodic
Ihldding of the exoskeleton results in a stepwise pattern of growth.
Mltamorphosis, which involves gross morphological changes (e.g., from larva to
.dult) occurs at one of these molts and is therefore partly controlled by
.cdysteroids (Hampshire and Horn, 1966).
Ecdysteroids control ecdysis (the replacement of the exoskeleton at
tnolting) and promote advancement to the next developmental stage. In doing
these steroids stimulate the expression of genes for this next developmental
~}erlod.

In contrast, JH regulates the type (developmental stage) of exoskeleton

,nede at the time of the molt and the presence of JH above a threshold titer
~)romotes

retention of the current developmental stage (Laufer et aI., 1986). JH

plays a role in the endocrine regulation of reproduction in insects (Laufer et
4

aI., 1986). In female insects, JH stimulates separation of the new follicles from
the germarium, previtellogenic growth of the oocytes, and vitellogenesis
(production of this yolk protein). In males, JH stimulates spermatogenesis,
sexual maturation, and mating activity. These roles of JH can be demonstrated
by removing the corpora allata, which inhibits oogenesis in most species as well
as male reproductive activity. Treatment with JH or an analogue of JH can
restore these activities to individuals lacking a corpora allata (Raabe, 1989).
The key factors in the control of the circulating titer of JH are the rate of
its production by and immediate release from the corpora allata.

However,

control of JH synthesis is neither well understood, nor similar among all insect
species studied. In many species, the corpora allata are directly connected to
the brain by neurosecretory axons. In addition, the corpora allata appear to be
regulated by other hormones in the hemolymph. The level of JH in the
hemolymph is reduced and further regulated by esterases which break down the
MF. The complete removal of JH from the hemolymph appears to be necessary

in many species for metamorphosis to occur.

Regulation of reproduction and metamorphosis in crustaceans

Ecdysteroids and JH-like hormones are also found in crustaceans.
Because of the close phylogenetic relationship of insects and crustaceans, it is
not surprising to find that they share similar hormone systems.

Ecdysteroids

have been detected in all crustaceans studied and are produced by the Yorgans, paired endocrine glands found in close association with the brain. The
major ecdysteroid in both insects and crustaceans is 20-0H ecdysone (Laufer
et aI., 1986). A compound that is chemically related to JH, methyl farnesoate
5

(MF), has also been detected in crustaceans (Laufer et aI., 1987a). This
sesquiterpenoid is similar to JH III, an analogue of JH, except that MF contains a
double bond rather than an epoxide between carbons 10 and 11 (Figure 1)
(Laufer et aI., 1987a). Crustacean hemolymph contains MF levels that are
similar to the JH levels found in insect hemolymph (Laufer et aI., 1987a). While
the exact functions of MF are not yet known, it is produced by the mandibular
organs (MOs), a pair of glands that resemble the insect corpora allata (Borst and
Laufer, 1990; Laufer et aI., 1986).
The presence of MF delays metamorphosis in the larvae of the lobster,

Homarus americanus (hereafter referred to as Homarus), as JH does in insects
(Borst et aI., 1987). MF synthesis is correlated with vitellogenesis and the
ovarian cycle. High levels of MF synthesis coincide with periods of active
vitellogenesis (Laufer et aI., 1987b). Also, ovarian growth is promoted by the
implantation of MOs (Borst et aI., 1987b). MF also seems to stimulate
reproductive behavior in males (Laufer et aI., 1993).

Regulation as a way to understand function
In spite of the observations mentioned above, the roles of MF are still
poorly defined. One approach to investigating these roles is the manipulation of
MF levels in vi\lo. The discovery and identification of factors that regulate MF
··YY,",'UIU

be a useful step toward that goal.
The crustacean eyestalk is a source of many neuroendocrine peptides,

ost of which are stored and released by the sinus gland (SG), a
neuroendocrine gland in the eyestalk of decapod crustaceans (De Kleijn, 1995).
The effects of theeyestalk on reproductive and metamorphic functions have
6

Figure 1.

Chemical structures of juvenile hormone III (JH III) and methyl

farnesoate (MF). MF differs from JH III in that MF contains a double bond
rather than an epoxide between carbons 10 and 11 (Laufer et aI., 1987a).
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been known for some time. Reproduction is inhibited by an eyestalk factor and
metamorphosis is disrupted by eyestalk ablation (removal) (Laufer et aI., 1986).
Neuropeptides synthesized in the SG of the eyestalk regulate many crustacean
functions, including glucose levels (through CHH, crustacean hyperglycemic
hormone) and ecdysteroid levels (through MIH, the molt inhibiting hormone).
The SG of the eyestalk is a,lso an apparent regulator of MF production.
Eyestalk removal increases both MF synthesis by the MO and circulating MF
levels in several crustaceans, including the spider crab Ubinia emarginata
(Laufer et aI., 1987b) and Homarus (Tsukimura and Borst, 1992). Crude SG
extracts inhibit MF production both in vivo and in vitro, indicating that this tissue
may contain a peptide that inhibits mandibular organ function (MOIH, mandibular
organ inhibiting hormone).
Several SG peptides have been reported to influence MF production. In
the crayfish Procambarus clarkii, pigment dispersing hormone (PDH) inhibits MF
synthesis. PDH may be related to MOIH (Tsukimura et aI., 1993). Another
crayfish hormone, red pigment concentrating hormone (RPCH) doubles MF
eynthesis and may be similar to compounds that stimulate MF production
(Landau et aI., 1989).
Some MOIHs appear to have hyperglycemic effects. The crustacean
hyperglycemic hormone (CHH) family includes CHHs, vitellogenic inhibiting
hormone (VIH) and molt inhibiting hormone (MtH). This hormone family is
defined based on amino acid sequence, molecular weight, number of amino
acids and cysteine content of its members. In some species, substances
defined as MOIHs based on their regulatory effect on the MO also fit these
criteria. These studies suggest that MOtH may have multiple roles in
9

crustaceans. Both CHHs and MOIHs also have a high degree of species
specificity (Liu and Laufer, 1996).
Purified Libinia MOIH gave a maximum of 70% inhibition of MF production
by disaggregated Libinia MO cells when compared to the response of these cells
to crude SG extract (Homola, 1989). Because inhibition by Libinia MOIH is not
complete, it is thought MF production may be regulated cooperatively by a group
of compounds. This type of control would allow for the precise regulation of MF
production (Liu and Laufer, 1996). Biogenic amines are one type of compound
that may act synergistically with the SG neuropeptides (Homola et aI., 1989).
Biogenic amines are produced and released by neurons. In Libinia, inhibition of
MF synthesis by biogenic amines alone has been observed. Octopamine,
epinephrine and serotonin had inhibitory effects on MF synthesis by dispersed

Llbinia MO cells, in the case of serotonin, at physiological concentrations
(Homola, 1989). Serotonin has also been known to act as a crustacean
neurohormone affecting behavior and morphology (Homola, 1989).
MOIHs have also been isolated and sequenced in the cancer crab,

Clncer pagarus. These peptides are SG products, fractionated from the crude
extract, which inhibit MF production in vitro. In sequence they resemble
."embers of the CHH family of crustacean hormones, especially the molt-,
vitellogenesis-and gonad inhibiting hormones of C. pagarus and other
Irustaceans (Wainwright, 1996).

entification of regulation of MF synthesis in the lobster
It has been demonstrated in Homarus that MF production by the MO is
~f%ltrnllorl

by the sinus gland in the eyestalk. Eyestalk ablation results in
10

hypertrophy of the cells of the MO and an increase in MF production; in other
words, ablation relieves inhibition by the eyestalk.

Unilateral ablation results in

an increase in MF production to a lesser extent than bilateral ablation does
(Tsukimura and Borst, 1991). The injection of a crude homogenate of the SG
Into lobsters that have been eyestalk ablated results in a decrease of MF levels
to almost undetectable levels. MF levels return to the pre-treatment elevated
levels after at least 12 h (Tsukimura and Borst, 1992).
In defining the Homarus MOIH it is helpful to determine the chemical
nature of this substance.

Evidence that the SG product that regulates MF

production is a peptide hormone is that cyclic nucleotides seem to be second
messengers for the MOIH in Homarus.

Cyclic nucleotides (e.g. cAMP and

cGMP) are known to be second messengers for peptide hormones including
CHH (Tsukimura et aI., 1993). Cyclic nucleotides seem to be second
messengers for the MOIH in Homarus indicating that this SG product is a
peptide hormone.

In this study, we designed an in vitro assay to study compounds that
directly control MF production by the Homarus MO. In this assay fragments of
Ihe MO were incubated in the presence of possible regulators of MF production.
1*"e levels of MF synthesis were measured by supplementing the culture
medium with methyl-labeled radioactive methionine. The methyl group of
methionine is transferred to farnesoic acid to produce MF (Claerhout et al.,

1'G6).

The radiolabeled MF can then be quantified. Two methionine

.reparations, each radiolabeled with a different isotopes (3H or 14C) were used
measure the synthesis of MF at two different periods.
11

During an initial

labeling period, the tissue was incubated in culture medium containing
methionine labeled with one radioisotope.

Incorporation of this radioisotope

into MF allowed the initial, baseline, level of MF synthesis to be calculated.
After treating the tissue with a possible regulator of MF synthesis, the tissue was
incubated in culture medium containing methionine labeled with the second
radioisotope.

Incorporation of this second radioisotope into MF allowed the

level of MF synthesis after treatment to be calculated. A comparison of MF
Iynthesis during these two periods made it possible to determine the effect of
the compound on MF synthesis.
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Materials
Animals: American lobsters (Homarus americanus) were obtained from the
Massachusetts State Lobster Hatchery (Martha's Vineyard, MA) or from local
commercial suppliers in Massachusetts or Illinois. At the Marine Biological
Laboratory (MBL), animals were kept in fresh running sea water at ambient
temperature until needed. At Illinois State University, the animals were kept in
chilled (13C) tanks containing sea salts. In most cases, animals were eyestalk
eblated (using a piece of monofilament fishing line) 5 to 10 days prior to the
experiment. Bleeding was controlled by treatment with Avitene (MedChem,
Woburn, MA).

Aldiochemicals: [14C-methy~- and [3H-methy~-labeled methionine (with
Ipecific activities of 200 mCi/mmol and 55 mCi/mmol respectively) were
",urchased from DuPont I NEN (Boston, MA).

• llIne and culture medium: Homarus saline (Welsh and Smith, 1960) was
pared using deionized water and contained 463 mM NaCl, 15.7 mM KCI, 19.5
CaCI2, 3.9 mM MgCI2, 8.36 mM Na2S04 and 8.94 mM H3B03 (pH 7.6).
lture media (DMEM and Medium 199) were obtained from GibcoBRL
aeltersburg, MD) as dry powder. DMEM (Dulbecco's modified Eagle's medium)
prepared in a 1.5-fold concentration in pyrogen-free H20 and supplemented
2.81 mM NaHC03, 26604 mM sucrose, 19043 mM glucose, 25 mM HEPES,
U/ml Penicillin and 0.169 mg/ml Streptomycin. The final osmotic pressure

the OMEM was approximately 800 milliosmoles.
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After adjusting the pH to 704,

the medium was filter sterilized (0.22 ,Millipore). A second culture medium
used in this work was Medium 199 (M199). The salt concentration of M199 was
adjusted to those found in Homarus saline (343 mM NaCI, 10.3 mM KCI, 18.6
mM CaCI2-H20, 7.47 mM MgS04, and 4.17 mM NaHC03). The pH was
adjusted to 7.4.

Putative Regulators: Several putative regulators of the MO were tested,

including sinus gland extract (SGE), mandibular organ inhibiting hormone
(MOl H), crustacean hyperglycemic hormone (CHH) and serotonin. SGE was
prepared from sinus glands dissected from Homarus eyestalks and
homogenized in Homarus saline. Unless otherwise noted, culture media were
supplemented with the equivalent of 0.25 sinus glands per ml.
MOIH and CHH were generously provided by Dr. Ernie Chang (Bodega
Marine Laboratory, University of California, Davis, CA). These compounds
were isolated by Dr. Chang using reverse phase high performance liquid
chromatography (rpHPLC) from SGE. The eluting peaks were identified by their

In vivo biological activity.

For the trials in which these putative inhibitors were

tested, the culture medium was supplemented with the amount of peptide found

In either 0.25 sinus glands or 0.75 sinus glands per ml of culture medium,
depending on the treatment.
Serotonin (5-hydroxytryptamine, 5-HT) was purchased from Sigma
Chemical Co. (St. Louis, MO) and stored in a stock solution of 10 mM in 0.1 N
perchloric acid.

14

Methods
Dissection
The lobster mandibular organ (MO) is a soft, beige tissue with a fanfolded edge (Figure 2; Borst et aI., 1994). It is located ventrally in the lobster,
wrapped around and loosely attached to the apodeme of the mandibular
abductor which anchors the mandibles to the dorsal carapace (Borst et aI.,
1994). The fan-folded edge projects anteriorly and it is this fan-folded edge of
the MO where MF synthesis occurs (Borst et aI., 1994). The dissection was
performed as in Borst et al. (1994). Access to the MO was gained by removing
the dorsal carapace, clipping the mandibular abductor and removing the
cephalic lobes of the hepatopancreas. The MO was then removed from the
animal by detaching it from the mandibular abductor (by running a sharp tool
under it) and lifting it out of the animal.
Once removed, MOs were kept in Homarus saline on ice. Under a
dissecting microscope, the MOs were teased so that the fan-folded edge was
fully extended. A strip of tissue about 3 mm wide was cut from each MO along
this edge (see dashed line in Figure 2). The two strips were subdivided into a
total ot.70 to 80 fragments for use in the in vitro assay.

Double Label In vitro Assay
Three to four fragments of the MO were randomly picked and placed in
each well of a 24-well tissue culture plate (Falcon, Becton Dickinson, Lincoln
Park, NJ). Each treatment was tested in quadruplicate. All tests in an
experiment contained MO fragments from a single lobster.
15

Figure 2.

Cartoon of the mandibular organ (MO) of Homarus showing the fan-

folded edge. The region of the gland above the dashed line across fan-folded
edge is the portion used for in vitro studies (Borst et aI., 1994).
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Unless otherwise noted, the synthesis of MF by the MO fragments was
tested using a double-label procedure. This involved incubating tissue
fragments for a total of 5 h. MO fragments were incubated on an orbital shaker
set at a medium speed (approximately 60 rpm).

During the first two hours (T =

0-2), the fragments were incubated in 400 J.tl culture medium supplemented with
51lCi/mi [14C-methyl] methionine. At the end of this first incubation the
fragments were rinsed with unlabeled medium and then transferred to a second
well containing 400 J.tl culture medium without radiolabeled methionine. This
second incubation period lasted one hour (T

=2-3).

The fragments were then

moved to a third well containing 400 J.tl culture medium supplemented with 40
IlCi/ml [3H-methyl] methionine. Compounds being tested for their effects on

MF synthesis were added during both the second and third incubations (T =25). After two hours (T

=3-5), the MO fragments were removed from the 3H_

labeled medium, rinsed, and placed in ice-cold culture medium to prevent
additional incorporation of radiolabeled methionine into MF. In some
experiments the order of the radiolabels was reversed; however, we have no
reason to expect that this reversal had an effect on our results (see Figure 4).
The MO fragments were then extracted by homogenizing in 0.5 ml

Homarus saline with a 2-ml tissue grinder (Potter-Elvehjem, Fisher Scientific,
Pittsburgh, PA). The homogenate was transferred to a screw-capped culture
tube with a teflon-lined cap containing 2.5 ml acetonitrile. The homogenizer
was rinsed three times with 0.5 mL Homarus saline or 2% NaCI, and the rinses
were added to the culture tube.

The culture tubes were vortexed, 1 mlof

hexane was added to each tube to extract the MF and the tubes were again
J

vortexed. After chilling on ice for ten minutes, the tubes were centrifuged (2000
18

rpm x 5 min, 6°C) to separate the phases. The hexane phase that contained
the MF and was analyzed by scintillation counting and/or HPLC.

Analysis of MF synthesis by scintillation counting
It was necessary to determine the amount of radioactivity in the medium
and the specific activity of the methionine in each culture well to calculate the
amount of MF synthesized by the MO fragments in each well. Therefore, after
each of the three incubations, 5 III of culture medium was placed in a 4 ml
scintillation vial. Three ml of scintillation cocktail (Scintiverse, Fisher Chemical
Co., Pittsburg, PA) were added to each vial. The samples were analyzed on a
scintillation counter (Packard Tri-Carb 2200CA, Packard Instruments, Downers
Grove, IL) to determine the amount of each radioisotope (DPM: disintegrations
per min) in the incubation fluid.
The amount of radiolabeled MF synthesized during each labeling period
was calculated in the following way. First, the final specific activity (a value
expressed in units of Curies/mol) of the methionine in the culture medium in
each culture well was calculated. The amount (in moles) of radioactive
methionine present in each well was calculated by dividing the DPM of the
culture medium (determined from the DPM for the 5 III aliquot) by the known
specific activity of the radioactive compound. The amount of radiolabeled
methionine was then added to the amount of unlabeled methionine (from the
talogue description of DMEM) in the culture medium to determine the molarity

f the methionine (labeled and unlabeled) present. The amount of radioactivity

neach well was then divided by the total methionine present to determine the
djusted specific activity.
19

Two aliquots (200

~I

each) of the extracted MO samples were also

analyzed by scintillation counting. The adjusted methionine specific activity in
the samples was used to convert the DPM of MF in each sample to amount
(moles) of MF synthesized by that tissue.

By making these corrections for both

the [3H]-methionine and the [14 C]-methionine, it was possible to compare the
amount of MF synthesized during the first incubation period with the amount
synthesized during the second incubation period.

Levels of inhibition of MF

synthesis are expressed as percentages of MF production during the second,
treated period as compared to MF production during the first, control period.

HPLC Analysis

An aliquot of the hexane extract of some samples was analyzed by HPLC
to confirm that radioactivity in the extract detected by scintillation counting was
MF.

Normal phase HPLC was performed using a LKB Bromma 2185 HPLC with

the detector wavelength of 206 nm. Sample extracts of homogenized MOs
incubated in vitro were separated with a silica column (51l. 4.6 mm x 25 cm)
using a solvent of 1% ether in hexane (2 ml/min). Fractions were collected
every 30 sec as they eluted from the HPLC. The samples were analyzed in the
scintillation counter to identify fractions containing radiolabeled compounds.
The time at which these samples eluted off the column was compared with the
retention time of the MF standard to determine whether the fractions containing
radioisotopes coeluted with MF.

20

Results
Optimizing Conditions for the Double Label Experiment
MF synthesis was measured in MO fragments incubated in two culture
media (DMEM and M199). When DMEM was used, MF synthesis during the
second labeling period was 46% of the level observed in the first period (Figure
3).

When M199 was used, synthesis during the second labeling period was

29% of that observed in the first period.

DMEM was used in subsequent

experiments because MF synthesis in the second labeling period was higher in
this medium than in M199.
Ideally, the MO tissue would synthesize similar amounts of MF during
both labeling periods.

However, even in the DMEM, MF synthesis was reduced

considerably in the second labeling period. The basis for this decrease was
investigated in several ways. One possible reason for this difference was that
the [14C-methy~- and [3H-methy~ methionine preparations were different in
some way, or that there was an error in the method used to calculate MF
synthesis. To test for these possibilities, MOfragments were incubated for 2 h
in culture medium containing a methionine mixture labeled with both
radioisotopes. The amount of MF synthesized during the incubation was
calculated using the incorporations of each radiolabel after adjusting its specific
ctivity to reflect the total methionine in the culture medium. The level of
ncorporation of 3 H into MF was 83% (0.4 SE, n=4) of the incorporation of
ethionine labeled with

14C

into MF.

An additional test for possible differences in the two radioactive
ethionine preparations was performed by switching the order of these labels in
21

Figure 3.

Comparison of culture media, M199 and DMEM. Levels of MF

synthesis during the second labeling period are compared to levels of MF
synthesis during the first labeling period. This value is expressed as a percent.
Each bar represents mean ± SE (n

=4).
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the double label experiment. The order in which the two methionine
preparations were used had a minimal effect on the synthesis of MF by the MO
fragments (Figure 4).
Finally, the identity of the radiolabeled material produced by the MO
fragments was determined to confirm that MF was the labeled product. Hexane
extracts of tissue lab,eled with both [3H-methy~- and [14C-methy~ methionine
were analyzed by normal phase HPLC. As can be seen in Figure 5, scintillation
analysis of fractions separated by HPLC showed a single peak of radioactivity
for both radioisotopes that eluted at the same time (about 5.0 min) as the MF
standard (Figure 6). This peak represents 84.5% (3.4, SE, n=17) and 84.4%
(1.2, SE, n=17) of the [3H]-labeled and [14C]-labeled material, respectively.

Double Label Experiment

SGE inhibited MF production by MO fragments in vitro. When the culture
medium for the 1-h rinse incubation and the second 2-h incubation was
supplemented with SGE, MF synthesis by MO fragments treated with SGE was
lower than that of tissue untreated with SGE (Figure 7). Two different doses of
SGE were tested to determine whether the inhibition of MF production by SGE
was a dose-responsive effect. Within the range from 0.01 to 0.1 SG
equivalents, the level of inhibition did not significantly differ (Student's t-test, p <

MOIH is an HPLC-separated fraction of crude SGE. This peptide also
as an inhibitory effect on MF levels in Homarus when used in in vivo. MOIH
artially inhibited MF production by MO fragments (Figure 8), but did not
epress MF synthesis as much as SGE did. To determine if the partial
24

Figure 4.

Label reversal trials. Tissue culture was supplemented with [3H_

methyn- or [14C-methyn methionine (40 Ci/ml and 5 Ci/ml, respectively). Bars
are labeled with the radioisotope with which culture medium was supplemented
for the first labeling period. Levels of MF synthesis during second labeling
period are compared to levels of MF synthesis during the first labeling period.
These values are expressed as a percent. Each bar represents mean ± SE (n
4).
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Figure 5.

Scintillation analysis of fractions collected from an HPLC separation

of the hexane phase of an MO tissue homogenate. Approximately 84% of the
radioactivity coeluted with the MF standard (see Figure 6) and is contain~d in
the fractions collected around 5.0 min.

27

5000

HPLC Analysis of MO Extracts
c=J 14C

4000

-3H

c
0 3000
.....,

.-CJ

..

ns

LL

00
N

--- 2000
:E
C-

o

1000

5

10

15

20

Figure 6.

Chromatogram of normal phase HPLC separation of the MF

standard using the standard HPLC conditions defined in the text. Graph shows
absorbance as a function of time as the standard was separated and eluted from
the column.
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Figure 7.

Trials testing dose response to crude Homarus sinus gland extract

(SGE). Culture medium was supplemented with the equivalent of 0.01 or 0.1
sinus glands per well. Each bar represents mean ± SE (n =4).
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Figure 8.

Testing effect on MF synthesis by possible inhibitors. SGE, MOIH

(mandibular organ inhibiting hormone) and CHH (crustacean hyperglycemic
hormone) were applied in 0.1 SG equivalent aliquots.
mean ± SE (n

=4).
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CHH

response to MOIH reflected an inadequate amount of the peptide, MO fragments
were tested with two doses of MOIH (0.1 SG and 0.3 SG equivalents) (Figure 9).
These two doses gave equivalent responses, suggesting that the partial
response to MOIH was not due to insufficient peptide.
The crustacean hyperglycemic hormone, CHH, was also isolated by
HPlC separation of the SGE crude extract. CHH is just one member of a family
of crustacean hormones with the same name. MOIH is thought to be part of the
CHH family of hormones, all of which have similar structures and may share
functions (liu and laufer, 1996). CHH did not have any inhibitory effect on MF
production in vitro (Figure
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To test whether the 0.1 SG equivalent dose of

this peptide was simply too low to illicit a response, a three-fold dose (0.3 SG
equivalents) was tested and also failed to give an inhibitory effect (Figure 9).
Serotonin (5-HT, 5-hydroxytryptamine), which inhibited MF production by
disaggregated Libinia MO cells (Homola, 1989), was tested in the in vitro
experiment of Homarus MOs.

No inhibition of MF production was seen by

serotonin (Figure 10). This level is above the reported physiological level for
Homarus (10-8 ) (livingston et aI., 1980). To test whether serotonin generated
any enhancement of the inhibitory effect of SGE (which was short of 100%),
additional experiments were performed in which SGE was combined with
serotonin for the last 3 h of incubation for some trials. This combination did not
have any greater inhibitory effect on MF production than did SGE alone.
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Figure 9.

Trials testing dose response to different levels of MOIH (mandibular

organ inhibiting hormone) and CHH (crustacean hyperglycemic hormone).
Culture medium was supplemented with the equivalent of either 0.1 or 0.3 sinus
glands per well. Each bar represents mean ± SE (n = 4).
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Figure 10.

The effect of serotonin on levels of MF synthesis.

Culture medium

was supplemented with either 0.25 SG equivalents per ml SGE or 10-5 M
serotonin (5-HT or 5-hydroxytryptamine), or both of these treatments combined.
Each bar represents mean ± SE (n

=4).
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Discussion
The in vitro assay of the lobster MO proved to be a satisfactory system
with which to study the direct control of MF synthesis by the gland. The MO is
large and easily dissected from the animal. In addition, despite using only small
amounts of tissue, the levels of MF generated are quantifiable by the methods
used here (scintillation analysis of radiolabeled MF).
Levels of MF synthesis by lobsters vary among MOs even from a single
individual (Borst et aI., 1994). Because of this variability, no control or baseline
level of MF synthesis could be defined for the lobster. As a result, the effects of
possible inhibitors of MF synthesis had to be examined with respect to controls
performed on the MO fragments from the same animal during the same
experiment. The double label experiment was devised to give an individual,
internal standard for the untreated level of MF synthesis for each quantity of MO
tissue assayed. That is, MF synthesis by the fragments was normalized to the
initial level of synthesis. Comparisons of percent initial MF synthesis could not
be made across experiments. By using two different radiolabels, the relative
amount of MF synthesized before and after the treatment could be compared.
As stated previously, the results of the double label experiments are expressed
as a ratio of MF synthesis during the second labeling period to the MF synthesis
during the first labeling period (expressed as a percentage). Thus, these values
of percent of initial MF synthesis provide a relative measure of MF synthesis
regardless the initial levels of MF synthesis for that tissue sample.
Even for the control trials, for which there was no treatment during the
second labeling period, the tissue was not as active during the second period as
40

during the first. In other words, MF synthesis during the second period was
never 100% of the initial synthesis (Figures 3, 4 and 7-10). This reduction of
synthesis during the second labeling period could be the result of a shortage of
MF precursors, including farnesoic acid, or of other components of the MF
synthesis pathway. The cells also may be dying. Studies are currently being
done using microscopy to look for morphological changes in MO tissue that has
been incubated in OMEM in these conditions for 5 h (Ernest Couch, work in
progress).

Because of this consistent decrease in MF synthesis over time, the

effects of putative inhibitors could not be understood by comparing them with
100% initial MF synthesis. Instead, to assess inhibition by the treatment
compounds, the levels of percent initial MF synthesis were compared among
control and treatment groups.
An optimal level of MF synthesis during hours 3-5, averaging
approximately 50% of initial, was achieved consistently with concentrated DMEM
and MOs from eyestalk ablated lobsters. Through the label reversal
experiment, it was determined that the order of the radiolabels did not have a
significant effect on the rate of incorporation of the radiolabeled methyl group
into MF (Student's t, p < 0.01). For some experiments, the culture medium was
supplemented with [3H-methyl] methionine during hours 0-2 and with [14 C_
methyl] methionine for hours 3-5.

For others, this order was reversed. This

was not considered to have any effect on the experimental conditions.
The in vitro assays of crude SGE gave the expected results. SGE
inhibited MF production sufficientfy for us to consider it a direct effect (in Figure
7, percent initial MF synthesis was 7.5% with SGE compared with 45% for the
control). We hypothesize that this is as complete an effect as can be observed
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in vitro; therefore, the degree of inhibition by SGE was used as a standard

measure of complete inhibition for these studies.
MOIH did not have as great an inhibitory effect as did SGE. This
substance, isolated from the crude SGE by Chang, was identified by its effects in
vivo in Homarus where it generated complete inhibition of MF synthesis. The

partial inhibitory effect in vitro suggests that it may work synergistically with
another substance in vivo.

Since MOIH completely inhibits MF synthesis in vivo

in animals whose SGs have been removed by eyestalk ablation, it is unlikely that
the synergistic substance is a product of the SG. Instead, the substance with
which the MOIH could work synergistically could be a biogenic amine delivered
to the MO by neuronal contacts and therefore not dependent on the presence of
the eyestalk. The MO may be innervated by neurosecretory axons, as are the
homologous corpora allata of insects (Raabe, 1989), but this has not been
determined for Homarus.
CHH had no inhibitory effect on the rate of MF synthesis by MO fragments
in this in vitro study. CHH seemed a likely candidate for a MOIH in Homarus
because some Homarus CHH-isoforms have been shown to act as gonad
stimulators and molt inhibitors, roles described for the MOIH in some other
species (De Kleijn, 1995). However, this HPLC fraction of Homarus SGE did
not have MF-inhibiting activity. The CHH was identified by Chang by its activity
in vivo (as was the MOtH); therefore, the lack of MF-inhibiting activity in vitro of

the CHH appears not to be due an absence of overall activity.
Serotonin alone had no inhibitory effect on MF synthesis by the MO
fragments. The concentration used in this study, 1a-5M, is higher than the
circulating titer in Homarus; it is not a physiologically significant titer (Livingston
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et aI., 1980). It follows that at lower concentrations, closer to those found in
vivo, serotonin would also not have an inhibitory effect on MF synthesis.
The doses of SGE, MOIH and CHH used in this study should have been
sufficient to elicit a response. .The 0.1 or 0.3 sinus gland equivalent aliquots of
the peptides applied to the tissue in the experiment are in excess of the amount
of peptide circulating in vivo relative to the amount of tissue used in the assays.
Thus, the lack of an inhibitory effect by some substances tested here is not due
to an ineffectively small dose of these compounds.
While serotonin does not affect MF synthesis alone or in combination with
SGE, it is possible that this biogenic amine may act synergistically with a fraction
of the crude SGE. In future studies a treatment of MOIH and serotonin together
will be applied to theMO tissue to determine whether this combination inhibits
MF production completely. Other future studies include the evaluation of the
SGE, MOIH, CHH and serotonin on MF synthesis by dispersed Homarus MO
cells. The isolation of MO cells would control for effects of substances which
may be delivered to the MO by neurons (which may remain in the fragment
preparation used in these in vitro studies).
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Conclusions
Under the conditions of this in vitro assay, Homarus MO tissue actively
synthesized MF. When exposed to SG extract, which inhibits MF production in
vivo, MF synthesis levels were depressed. MOIH, a peptide isolated from the

SGE by HPLC which inhibits MF production in vivo, also had an inhibitory effect
on levels of MF synthesis in vitro.

CHH, another peptide isolated from the SGE,

thought to have some functional homology with MOlH because of structural
similarities, did not have an inhibitory effect on MF synthesis in vitro. Serotonin,
which inhibits MF synthesis by dispersed Libinia MO cells (Homola, 1989), did
not have an effect on MF synthesis by MO tissue in this in vitro study. The
partial inhibition of MF synthesis by MOIH suggests that it may act
synergistically with a non-SG substance in ,vivo. Future studies will involve
combining possible synergistic substances with MOIH in these in vitro
conditions.
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